Correlation Between AstraZeneca PLC and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Bristol Myers Squibb, you can compare the effects of market volatilities on AstraZeneca PLC and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Bristol Myers.
Diversification Opportunities for AstraZeneca PLC and Bristol Myers
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between AstraZeneca and Bristol is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Bristol Myers go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Bristol Myers
Considering the 90-day investment horizon AstraZeneca PLC ADR is expected to generate 0.66 times more return on investment than Bristol Myers. However, AstraZeneca PLC ADR is 1.51 times less risky than Bristol Myers. It trades about 0.33 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.35 per unit of risk. If you would invest 6,826 in AstraZeneca PLC ADR on January 27, 2024 and sell it today you would earn a total of 677.00 from holding AstraZeneca PLC ADR or generate 9.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
AstraZeneca PLC ADR vs. Bristol Myers Squibb
Performance |
Timeline |
AstraZeneca PLC ADR |
Bristol Myers Squibb |
AstraZeneca PLC and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AstraZeneca PLC and Bristol Myers
The main advantage of trading using opposite AstraZeneca PLC and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.AstraZeneca PLC vs. Shuttle Pharmaceuticals | AstraZeneca PLC vs. Lifecore Biomedical | AstraZeneca PLC vs. Lucy Scientific Discovery |
Bristol Myers vs. Shuttle Pharmaceuticals | Bristol Myers vs. Lifecore Biomedical | Bristol Myers vs. Lucy Scientific Discovery |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |